Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hideghety

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Physics in Medicine and Biology|May 9, 2002
Towards in vivo monitoring of neutron distributions for quality control of BNCTW F A R Verbakel, K Hideghety, J Morrissey, et al.
Investigational New Drugs|June 5, 2014
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)A Ruzsa, M Sen, M Evans, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Physics in Medicine and Biology|May 9, 2002
Towards in vivo monitoring of neutron distributions for quality control of BNCTW F A R Verbakel, K Hideghety, J Morrissey, et al.
Investigational New Drugs|June 5, 2014
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)A Ruzsa, M Sen, M Evans, et al.
Pageof 1